Financial Analysis: Autonomix Medical (AMIX) and Its Competitors

Autonomix Medical (NASDAQ:AMIX) is one of 237 public companies in the “Surgical & medical instruments” industry, but how does it compare to its peers? We will compare Autonomix Medical to related companies based on the strength of its dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations.

Insider and Institutional Ownership

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 47.7% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by company insiders. Comparatively, 15.4% of shares of all “Surgical & medical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Autonomix Medical and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-542.11%	-236.92%
Autonomix Medical Competitors	-574.36%	-156.80%	-27.37%

Valuation & Earnings

This table compares Autonomix Medical and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Autonomix Medical	N/A	-$15.43 million	-0.21
Autonomix Medical Competitors	$1.03 billion	$10.01 million	-7.18

Autonomix Medical’s peers have higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Autonomix Medical and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	1	0	3.00
Autonomix Medical Competitors	1946	4959	9224	273	2.48

Autonomix Medical currently has a consensus target price of $28.00, suggesting a potential upside of 745.92%. As a group, “Surgical & medical instruments” companies have a potential upside of 20.48%. Given Autonomix Medical’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Autonomix Medical is more favorable than its peers.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.